BioSpace News Archive

Faxitron, a global leader in best-in-class imaging systems for medicine and life science research, today announced plans to double its North American commercial team in 2018.

Nordson MEDICAL announced today that it has launched a new website at www.nordsonmedical.com.

On December 28, 2017, Delcath entered into exchange agreements with two institutional investors pursuant to which those investors were issued, in exchange for satisfaction in full of those notes.

Flemming Ornskov, MD, M.P.H., Chief Executive Officer and John Miller, Interim Chief Financial Officer will host the investor and analyst conference call at 9:00 am EST / 14:00 GMT.

The data demonstrate that AFM13 was well-tolerated and showed promising therapeutic efficacy both in combination with the anti-PD-1 antibody Keytruda in Hodgkin lymphoma and as monotherapy in CD30-positive lymphoma.

ADM Tronics Unlimited, Inc., a technology-based developer and manufacturer of innovative technologies has authorized its subsidiary, Aurex International Corporation (“AIC”) to begin advertising its new hearing protection product, Tinnitus Shield™ in “Tinnitus Today” - the official publication of the American Tinnitus Association.

The company’s preliminary fourth quarter revenue was $53.3 million, compared to $23.8 million in the fourth quarter of 2016.

The company entered into an agreement to acquire a global, exclusive, transferable license to the eNOGenerator.

The Board has resolved to issue new options to employees of the Company.

On January 19, 2018, the global first clinical case of MitralStitch™ mitral valve repair system was completed at Yunnan Fuwai Hospital, China.